Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection

Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders have demonstrated considerable potential for molecular medicine. Recent identification of the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain organs may demonstrate higher...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Duan, Dongsheng, Li, Qiang, Kao, Aimee W., Yue, Yongping, Pessin, Jeffrey E., Engelhardt, John F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 1999
Matèries:
Gene Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC113092/
https://ncbi.nlm.nih.gov/pubmed/10559355
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars